Survey of current practices and opinions of German Society of Gynecologic Endoscopy members regarding the treatment of ovarian neoplasia by robotic surgery.

Archives of Gynecology and Obstetrics
J S M ZimmermannE F Solomayer

Abstract

As data on this topic are sparse and contradictory, we aimed to ascertain the opinions of the members of the German Society of Gynecologic Endoscopy (AGE) regarding the use of robotic surgery in the treatment of ovarian malignancies. In 2015, an anonymous questionnaire was sent to AGE members to assess their views on the treatment of ovarian malignancies by robotic surgery according to T stage and the current treatment practices in their facilities. Of the 228 respondents, 132 (58%) were fellows or attending physicians and 156 (68%) worked at university hospitals or tertiary referral centers. Most [n = 218 (96%)] respondents reported treating < 10% of their patients using robotic surgery. Respondents felt that T1 and borderline ovarian tumors, but not T2 (51%) or T3/4 (76%) tumors, should and could be treated by robot surgery. 162 (71%) respondents considered the currently available data on this subject to be insufficient, and 42% indicated their willingness to participate in clinical studies on the applicability of robotic surgery to the treatment of T1/2 ovarian tumors. The majority of AGE members surveyed considered robotic surgery to be an option for the treatment of T1 ovarian malignancies and borderline ovarian tumors. Ho...Continue Reading

References

Sep 1, 1994·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K. SjövallN. Einhorn
Dec 18, 2001·American Journal of Obstetrics and Gynecology·V J SmidtW W Hurd
Mar 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert E BristowF J Montz
Oct 8, 2003·Gynecologic Oncology·Pedro T RamirezCharles Levenback
Mar 23, 2006·World Journal of Urology·Ben J ChallacombeProkar Dasgupta
Dec 24, 2008·Obstetrics and Gynecology·Jamie N Bakkum-GamezWilliam A Cliby
Jan 14, 2009·Gynecologic Oncology·Mohamed MabroukPedro T Ramirez
Aug 8, 2009·Clinical Obstetrics and Gynecology·Jennifer E ChoFarr R Nezhat
Jan 29, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Maria LeeEun Ji Nam
Aug 13, 2011·The Cochrane Database of Systematic Reviews·Ahmed ElattarRaj Naik
Nov 17, 2011·Annals of Surgical Oncology·Fabio GhezziMassimo Franchi
Nov 30, 2011·Current Opinion in Obstetrics & Gynecology·Ga Won Yim, Young Tae Kim
Jan 1, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H S KimY B Kim
Apr 16, 2013·American Journal of Obstetrics and Gynecology·Hyun Jong ParkYoung Tae Kim
Apr 1, 2014·JSLS : Journal of the Society of Laparoendoscopic Surgeons·Noah RindosValena Wright
May 29, 2014·Journal of Minimally Invasive Gynecology·N I El KhoulyL T Chuang
Jan 28, 2015·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·J SerorF Lécuru
Mar 27, 2015·The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS·Ching-Hui ChenWei-Min Liu
Apr 11, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Lesley B ConradMichael Frumovitz
Nov 6, 2015·Journal of Minimally Invasive Gynecology·Lucas MinigVanna Zanagnolo
Jan 8, 2016·Current Treatment Options in Oncology·Anna FagottiGiovanni Scambia
Oct 30, 2016·American Journal of Obstetrics and Gynecology·Minna M MäenpääJohanna U Mäenpää
Nov 20, 2016·Journal of Minimally Invasive Gynecology·Valerio GallottaGabriella Ferrandina
Dec 19, 2016·Journal of the Turkish German Gynecological Association·Ibrahim AlkatoutJohannes Ackermann
Jan 21, 2017·Journal of Minimally Invasive Gynecology·Vanna ZanagnoloLucas Minig
Jun 13, 2017·Best Practice & Research. Clinical Obstetrics & Gynaecology·A LucidiA Fagotti
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Aug 8, 2019·Journal of the National Comprehensive Cancer Network : JNCCN·Deborah K ArmstrongAnita M Engh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved